In Brief TMCO1 is an ER membrane channel that detects overfilling of calcium stores and restores calcium homeostasis, a function that is disrupted in human CFT dysplasia.
INTRODUCTION
Calcium ion (Ca 2+ ) is a highly versatile intracellular signal that controls many different cellular functions such as contraction, secretion, memory formation, gene transcription, cell growth, and cell death (Berridge, 1993; Clapham, 2007) . The endoplasmic reticulum (ER) is the main intracellular Ca 2+ store. Ca 2+ concentration in the ER ([Ca 2+ ] ER ) must be maintained in a steady state for proper Ca 2+ signaling (Berridge et al., 2003; Clapham, 2007) , and disarrangement of ER Ca 2+ homeostasis has been implicated in many severe diseases (Bezprozvanny and Mattson, 2008; Sammels et al., 2010; Tu et al., 2006) . Stimulation of cells with a variety of physiological stimuli leads to an inositol-1,4,5-trisphosphate (IP 3 )-mediated Ca 2+ release from ER and a depletion of Ca 2+ stores (Berridge et al., 2003) . Cells evolve a mechanism termed store-operated Ca 2+ entry (SOCE) or capacitative Ca 2+ entry (CCE) to refill the cell and ER Ca 2+ stores (Cahalan, 2009; Lewis, 2007; Putney, 2009) . It is known that Ca 2+ -release-activated Ca 2+ (CRAC) channels are responsible for the SOCE activity and Ca 2+ store refilling after store depletion (Brandman et al., 2007; Feske et al., 2006; Liou et al., 2005; Luik et al., 2008; Park et al., 2009; Prakriya et al., 2006; Roos et al., 2005; Vig et al., 2006; Zhang et al., 2005) . However, it remains unclear if there is a mechanism for ER to extrude the excess Ca 2+ when the store gets overloaded. Transmembrane and coiled-coil domains 1 (TMCO1)-defect syndrome is characterized by distinctive craniofacial dysmorphism, skeletal anomalies, mental retardation, ataxia, and many other clinical symptoms. A frameshift mutation in the TMCO1 gene has been identified as the pathogenic cause for this autosomal-recessive syndrome in the isolated Old Order Amish of northeastern Ohio (Xin et al., 2010) . The TMCO1 gene encodes a protein predicted to be 188 amino acids, and its c.139_140delAG mutation is predicted to result in severe protein truncation (p.Ser47X) leading to a loss of protein function. Non-Amish cases with a nonsense mutation in the TMCO1 gene (that results in a p.Arg87X truncation) have recently been reported (Alanay et al., 2014; Caglayan et al., 2013) . TMCO1-defect syndrome, initially thought to represent a distinct disorder, belongs to the genetically heterogeneous cerebrofaciothoracic (CFT) dysplasia spectrum (Alanay et al., 2014) .
The TMCO1 is a highly conserved protein among species (from slime-mold to human), implicating an evolutionarily conserved physiological function for TMCO1. However, the physiological function of TMCO1 is not known, nor the pathogenic mechanism of CFT dysplasia spectrum. Here, we provide biochemical and imaging, molecular and cellular, Figure S1 .
disruption, which could be the underlying pathogenic mechanisms for human CFT dysplasia spectrum.
RESULTS

TMCO1
Is an ER TransmembraneSpanning Protein TMHMM sequence analysis of TMCO1 predicted two transmembrane segments (amino acids 9-31 for TM1 and amino acids 91-109 for TM2) and a hydrophobic stretch (amino acids 143-154) (Figures S1A and S1B). To examine the subcellular localization of TMCO1, myctagged TMCO1 was expressed in HeLa cells. Immunostaining of myc-TMCO1 showed perfect colocalization of myc-TMCO1 with ER tracker ( Figure 1A) , and the first transmembrane segment (TM1) of TMCO1 is essential for its ER localization ( Figures S1C and S1D ). Surface-labeling of two-side-tagged TMCO1 demonstrated that TMCO1 is not a plasma membrane protein ( Figure 1B) . We next generated a polyclonal antibody against TMCO1 that is able to recognize the endogenous TMCO1 protein in immunoblotting analysis. Percoll gradient fractionation of the post-nuclear supernatant (PNS) revealed that endogenous TMCO1 is associated with the ER markers (calnexin, P62) but not the mitochondrial (Tim 23) or Golgi (GM130) marker ( Figure 1C ). TMCO1 was presented in the membrane fraction ( Figure 1D ) and was resistant to alkaline extraction (Figure 1E ), demonstrating that TMCO1 is an ER transmembranespanning protein rather than a membrane-associated protein.
To determine the membrane topology of TMCO1, the PNS from HeLa cells expressing TMCO1 with either an N-myc or C-myc tag was digested with proteinase K in the presence or absence of Triton X-100 followed by western blot analysis. Bip, an ER luminal protein, was resistant to protease digestion unless the PNS was permeabilized by detergent, suggesting that the PNS membranes were intact ( Figure 1F ). In the same digestion conditions, both N-myc and C-myc tags were sensitive to protease digestion even in the absence of detergent, indicating that both N terminus and C terminus of TMCO1 are located in the cytoplasm ( Figures 1F and 1H ). Rtn-4a and Sec61-beta are known ER transmembrane proteins with low and high diffusion rates, respectively. Fluorescence recovery after photo-bleaching (FRAP) experiments revealed that the mobility of TMCO1 in the ER membrane was much higher than that of Rtn-4a and lower than that of Sec61-beta ( Figure 1G ), indicating that TMCO1 protein diffuses readily throughout the ER membrane. -containing ( Figure 2M ) and Ca 2+ -free medium ( Figure 2N ), indicating that TMCO1 overexpression causes increased Ca 2+ release from internal store.
Loss of TMCO1 Causes
Tetramerization of TMCO1 in Response to the Overload of ER Ca 2+ Store
Overload of ER Ca 2+ store caused by loss of TMCO1 prompted us to determine if TMCO1 acts as a Ca 2+ channel across the ER membrane to prevent the Ca 2+ store from overfilling. If this is the case, the functional TMCO1 channel must form an oligomeric complex comprising several TMCO1 subunits. To determine the TMCO1 stoichiometry, we applied similar biochemical techniques used previously to solve the stoichiometry of other channels. Co-immunoprecipitation results revealed that the full-length TMCO1, but not the 1-46 truncation, can coassemble with full-length TMCO1 ( Figure 3A ). Treatment of HeLa cell lysates with increasing concentrations of two different lysine-reactive crosslinkers produced cross-linked species with sizes of $40, $80, and $160 kDa on SDS-PAGE, consistent with the molecular masses of TMCO1 dimers, tetramers, and octamers, respectively ( Figures 3B and 3C ). The molecular mass of TMCO1 monomer is predicted $21 kDa, and the size of cross-linked oligomeric species observed are integer multiples of the $21 kDa TMCO1 monomer, indicating that the crosslinked products are integral homomultimers of the monomeric TMCO1 ( Figures 3B and 3C store-depleted (TG + EGTA), and Ca 2+ store-overloaded (8% ethanol) cells ( Figure 3D ). ER Ca 2+ store depletion caused a slight decrease in the cross-linked tetramer intensity of TMCO1 ( Figure 3D ), while the ER Ca 2+ store overload resulted in a 2.5-fold increase in the intensity of TMCO1 tetramers ( Figure 3D tration from a resting of $500 mM to an overloaded state of $650 mM. In contrast, TG depleted the ER Ca 2+ effectively (Figure 3E) . Accordingly, the FRET signal was increased $20% upon ethanol-induced ER Ca 2+ overload and reduced to $À5% when ER Ca 2+ was depleted ( Figure 3F ), indicating that the TMCO1 undergoes oligomerization in response to ER Ca 2+ overload, and oligomerized TMCO1 (likely tetramers) rapidly disassembles when ER Ca 2+ store returns to resting levels. 1-46 TMCO1 truncations lost the capability of oligomerization in response to 8% ethanol treatments ( Figure 3F ). Further data demonstrated that the effects of 8% ethanol on the changes of D1ER and FRET were [Ca 2+ ] ER -dependent ( Figures 3G-3J ). This reversible assembly/disassembly of TMCO1 at the singlemolecule level in the native membrane environment was further determined by a photo-bleaching-step assay of TMCO1-GFP in TIRFM image. Continuous laser bleaching resulted in a stepwise decrement of GFP fluorescence at the diffraction-limited fluorescent spots in TMCO1-GFP-expressing HeLa cells (Figures 4A-4D ). The numbers of bleaching steps, ranging from one to a maximum of four, corresponding to the numbers of GFP molecules bleached at these spots ( Figures 4B-4D ). In resting HeLa cells, most of the spots ($65%) exhibited two steps to complete bleaching, and a small fraction ($20%) of these spots showed four bleaching steps ( Figures 4C and 4E ). ER Ca 2+ overload resulted in a decrease of two-step bleaching spots ($28%) and an increase of four-step bleaching spots ($64%) ( Figures 4D and 4E) , whereas depletion of ER Ca 2+ re- sulted in a completely opposite effect ( Figures 4B and 4E) . Therefore, TMCO1 is present in the ER membrane predominantly as dimers under resting conditions, and ER Ca 2+ overload induces dimerization of TMCO1 dimers to form tetramers ( Figure 4E ), which could be functional as a putative Ca 2+ channel across the ER membrane.
TMCO1 Forms a Ca 2+ Permeable
Channel across the ER Membrane To determine whether TMCO1 is capable of forming a Ca 2+ -permeable channel, we purified the TMCO1 proteins ( Figure S5 ) and reconstituted them into liposomes. We successfully recorded the single channel currents with a conductance of 66 pS from liposomes incorporated with the wild-type TMCO1 protein ( Figure 5A ). In contrast, the disease mutant protein (Ser47X truncation) did not show any detectable channel currents ( Figure 5B ). The monovalent cation:anion selectivity was determined from reversal potentials measured in the presence of a 10-fold KCl gradient. TMCO1 exhibited an average reverse potential of À49.4 ± 2.1 mV, which gave rise to an estimated P K /P Cl of 24.6, indicating that TMCO1 is a cation selective channel ( Figure 5D ). The Ca 2+ preference was then measured by the shift of reversal potential (DE rev ) when CaCl 2 was added to the bath solution ( Figure 5D ). Addition of 10 mM Ca 2+ into bath solution caused the reversal potential of TMCO1 shifted from À49.4 ± 2.1 mV to 5.1 ± 0.2 mV ( Figures 5A, 5D , and 5K; Table 1 ). This substantial shift of reversal potential suggested that TMCO1 was obviously selective for Ca
2+
. The conductance of TMCO1 reduced to 53.6 pS after adding 10 mM CaCl 2 in the bath solution (Table 1) , which displayed a little inhibition of conductance, a typical phenomenon of Ca 2+ permeation observed on the cyclic nucleotide-gated (CNG) ion channel (Almers and McCleskey, 1984; Frings et al., 1995) . Many Ca 2+ channels, such as CNG channels and IP 3 receptors (IP 3 Rs), also conduct monovalent cations in the absence of divalent cations (Bezprozvanny and Ehrlich, 1994; Finn et al., 1997; Foskett et al., 2007) .
To see if such conductance is present in vivo, we performed ER membrane patch clamp experiments. We made a tandem 4 3 TMCO1 expressing plasmid and found that expression of tandem 4 3 TMCO1 completely depleted the ER Ca 2+ content, indicating that tandem 4 3 TMCO1 is functional on ER ( Figures  S6A and S6B ). ER patch-clamp recording of tandem 4 3 TMCO1 expressing CHO cells mainly include two types of single channel: 12 out of 19 patches record small currents with 50.3 pS conductance ( Figures S6C and S6E ) and occasionally the large current $400 pS, which is probably the currents of IP 3 R or RyR. The dominant currents of tandem 4 3 TMCO1 has single channel conductance and open probability ( Figure S6D , Po = 0.66) similar to the current of TMCO1 recorded from reconstituted giant liposome. In contrast, we were not able to record such single channel conductance in control CHO cells. Therefore, we have recorded the in vivo TMCO1 channel activity on ER membrane by ectopic expression of tandem 4 3 TMCO1, supporting that TMCO1 is able to form a single channel conductance on ER membrane. To further confirm that TMCO1 is a Ca 2+ selective channel, we searched for the amino acids that potentially line the pore and interact with Ca
. We focused on the negatively charged residue aspartate at position 140 (D140) before the third hydrophobic stretch and changed it to either an alanine (D140A) or a glutamate (D140E) by site-directed mutagenesis. By functional evaluation of these mutations in Ca 2+ imaging experiments, we found that charge-neutralizing mutant (D140A) lost the Ca 2+ permeation function, whereas the charge-preserved mutant, D140E, still retained the ability to expel Ca 2+ out of ER ( Figures   5E and 5F ). These two mutants were then expressed, purified accordingly ( Figure S5 ), and reconstituted into giant liposomes followed by patch-clamp experiments. Our electrophysiological results revealed that D140E mutation significantly reduced the shift of reversal potential (E rev from À32.8 ± 0.6 mV to À3.9 ± 0.6 mV in the presence of 10 mM CaCl 2 , Figures 5G, 5H, and 5K; Table  1 ), indicating that D140E attenuates the Ca 2+ selectivity of TMCO1 channel. On the contrary, while D140A mutation showed a comparable K + preference (E rev = À48.9 ± 1.3 mV; P K /P Cl $22.4) as wild-type TMCO1, the reversal potential of D140A underwent almost no change after adding 10 mM Ca 2+ into the bath solution (Figures 5I-5K 
Mishandling
To examine the physiological role of TMCO1 in vivo, we generated TMCO1 knockout (KO) mice ( Figure S7A ). Mutant mice lacking TMCO1 were viable. However, the birth rate of KO pups is only 8.9%, which is much less than theoretical probability of 25% from heterozygous matings, suggesting an antepartum death of KO fetuses ( Figure 6A ). TMCO1-KO pups exhibited a reduced body size ( Figure S7B ), low survival rate ( Figure 6B ), and delayed osteogenesis ( Figures 6C and 6D ). Micro-CT images of adult TMCO1-KO mice revealed the craniofacial dysmorphism such as open cranial sutures ( Figure 6E ; Movies S1 and S2), flattened faces with shorten nasal bones ( Figure S7C ), and skull anomalies ( Figure S7D ). Furthermore, magnetic resonance imaging (MRI) of TMCO1-KO mouse brain showed significantly enlarged brain ventricles ( Figure 6F ), suggesting a mental retardation in TMCO1-KO mice. Consistently, adult TMCO1-KO mice manifest the significant deficiency in spatial recognition memory in a Y-maze task assay ( Figure 6G ). The TMCO1-KO mice also showed a significant deficiency in motor coordination in rotarod assessments ( Figure 6H ). Thus, our TMCO1-KO mice recapitulate the main clinical features of human TMCO1 defect patients including high rate of miscarriage, developmental delay, craniofacial dysmorphism, enlarged brain ventricles, mental retardation, and unstable gait (Alanay et al., 2014; Xin et al., 2010) , demonstrating that disruption of TMCO1 function in mice can cause similar symptoms to that of human CFT dysplasia spectrum. Notably, Ca 2+ imaging results revealed the significant overload of ER Ca 2+ in TMCO1-KO osteoblasts ( Figures 6I, 6J , S7E, and S7F), illustrating the severe mishandling of ER Ca 2+ after ablation of TMCO1 in osteoblasts, which could be the underlying mechanism for the craniofacial anomalies in CFT dysplasia spectrum.
Taken together, we propose a model of how the ER Ca 2+ store homeostasis is actively maintained by TMCO1. Our results show that TMCO1, a gene mutated in ''TMCO1 defect syndrome/CFT dysplasia spectrum,'' encodes an evolutionarily conserved ER transmembrane-spanning protein. 0 mM CaCl 2 À49.4 ± 2.1 À32.8 ± 0.6 À48.9 ± 1.3 66 ± 5.6 63.2 ± 9.6 81.7 ± 4.1 5 mM CaCl 2 À15.3 ± 0.5 À21.2 ± 1.2 À45.3 ± 0.4 56 ± 5.9 67.0 ± 17.3 67.1 ± 4.0 10 mM CaCl 2 5.1 ± 0.2 À3.9 ± 0.6 À47.5 ± 2.2 53.6 ± 6.3 62.0 ± 9.8 58.7 ± 5.5
The values of reversal potential (Erev, mV) and conductance of WT TMCO1, D140E, and D140A under asymmetric KCl solution (bath, 15 mM KCl; pipette, 150 mM KCl) with 0 mM, 5 mM, or 10 mM CaCl 2 in the bath solution were analyzed. The data are represented as the mean ± SEM, n = 4-7 patches. as well as correct protein folding and maturation (Austin, 2009; Xu et al., 2005) . The content of ER Ca 2+ store should be constantly monitored to maintain an ER Ca 2+ homeostasis.
STIM, an ER single-pass transmembrane protein, detects ER Ca 2+ depletion (Liou et al., 2005; Roos et al., 2005; Stathopulos et al., 2008; Zhang et al., 2005) , undergoes oligomerization (Baba et al., 2006; Liou et al., 2007; Wu et al., 2006) , and directly binds to Orai (Muik et al., 2008; Park et al., 2009) , causing the opening of the CRAC channel and initiation of Ca 2+ entry to convey Ca 2+ signals and to refill ER Ca 2+ stores Luik et al., 2008; Park et al., 2009; Prakriya et al., 2006; Roos et al., 2005; Vig et al., 2006; Yeromin et al., 2006; Yuan et al., 2009; Zhang et al., 2005 from ER into the cytosol (Berridge et al., 2003; Clapham, 2007) . A number of candidates have been previously shown to play a role as Ca 2+ passive leak channels, such as presenilins (Tu et al., 2006) , BCL-2/IP 3 R (Oakes et al., 2005) , Bax inhibitor-1 (Bultynck et al., 2012; Chae et al., 2004) , and ryanodine receptor in cardiac cells (Jiang et al., 2005) . Unlike the ''passive'' ER Ca 2+ leak channels, TMCO1 is an ''active'' Ca 2+ release channel that is assembled via homotetramerization in response to overfilled Ca 2+ in the ER (Figures 3 and 4) . The majority of TMCO1
do not assemble as homotetramers until the ER Ca 2+ content reaches a critical high level, indicating that the main function of TMCO1 channel is to prevent ER store from overload of Ca 2+ . Because $20% of TMCO1 exist as homotetramers in resting cells ( Figures 3F, 4C , and 4E), we consider that TMCO1 channel also accounts for a small proportion of basal ER Ca 2+ leaking activity. This is further supported by the fact that knocking-down of TMCO1 leads to overload of ER Ca 2+ store ( Figures S3D-S3F ), and overexpression of TMCO1 in WT cells almost depletes the ER Ca 2+ store (Figures S3G-S3I ). Ca 2+ influx system can also affect ER Ca 2+ homeostasis.
Capacitive Ca 2+ entry through SOCE machinery is one of the major pathways for Ca 2+ influx. SARAF, an ER located protein, has recently been discovered acting as an inhibitor of SOCE machinery to prevent excess Ca 2+ refilling (Palty et al., 2012) . Knockingdown SARAF can increase SOCE activity and thus causes ER Ca 2+ overloading. We consider that SARAF and TMCO1, which act on plasma membrane SOCE machinery and ER membrane, respectively, work together to prevent ER Ca 2+ overfilling and thus protect cells.
The TMCO1 gene has highly conserved amino acid sequence among species, and complementation of the human TMCO1 gene function can be achieved by expressing either C. elegans or zebrafish TMCO1 protein ( Figures S3J and S3K) , indicating that the TMCO1-mediated CLAC activity is an evolutionarily conserved mechanism for the homeostatic maintenance of ER Ca
2+
. Given that homeostatic maintenance of ER Ca 2+ is critical for proper Ca 2+ signaling and cell functions (Berridge et al., 2003; Clapham, 2007) , TMCO1 disease mutations-caused overload of ER Ca 2+ store and supernormal intracellular Ca 2+ signaling could be the underlying pathogenic mechanisms for human CFT dysplasia spectrum. Indeed, this has been confirmed by our TMCO1-knockout mouse model, which manifests severe mishandling of ER Ca 2+ in disease-affected cells such as osteoblasts from newborn KO mouse skulls and a delayed osteogenesis. Our TMCO1-KO mice successfully modeled the main clinical features of human TMCO1-defect syndrome such as developmental delay, craniofacial dysmorphism, enlarged brain ventricles and mental retardation, and unstable gait. We have See also Figure S7 and Movies S1 and S2.
previously described an autosomal-recessive syndrome, i.e., TMCO1-defect syndrome in the isolated Old Order Amish of northeastern Ohio (Xin et al., 2010) . Recently, more Turkish origins of TMCO1-defect syndrome have been reported (Alanay et al., 2014; Caglayan et al., 2013) . A combination of homozygosity mapping and whole-exome sequencing analysis of these patients of different origins have identified the pathogenic nonsense mutations in a single TMCO1 gene (c.139_140delAG mutation, p.Ser47X truncation for Amish; c.259 C > T mutation, p.Arg87X truncation for Turkish). TMCO1-defect syndrome shares many features with cerebrofaciothoracic (CFT) dysplasia and could be considered to belong to the genetically heterogeneous CFT dysplasia spectrum (Alanay et al., 2014) . The TMCO-deficient mouse model we created provides an important reagent for both molecular pathogenic mechanism studies and therapeutic target studies on CFT dysplasia spectrum in the future. In summary, we have identified the TMCO1 as a conserved, important regulator of ER Ca 2+ homeostasis. TMCO1 detects the ER Ca 2+ loading status, undergoes reversible tetramerization/disassembly, and tightly regulates the Ca 2+ content in ER store. This physiological function places TMCO1 as an important protective mechanism designed to prevent the overfilling of ER store with calcium ions.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection HeLa, HEK293T, and COS7 cells were propagated and maintained as American Type Culture Collection (ATCC) recommended. Several TMCO1 knocking-down cell lines were generated by infection with small hairpin RNA (shRNA) lentiviral transduction particles produced by Sigma and maintained in DMEM containing puromycin with 10% FBS.
[Ca 2+ ]cyto and [Ca 2+ ] ER Measurements Cytosolic Ca 2+ concentration was measured by Fura-2 or Fluo4 as described previously (Tang et al., 2003) , and [Ca 2+ ] ER measurements were done with D1ER probe as described before (Palmer et al., 2004) . For more details, see the Supplemental Experimental Procedures.
Chemical Cross-linking
The following homobifunctional reagents were used for protein cross-linking: the lysine-reactive N-hydroxysuccimide esters DSS (water-insoluble, membrane permeable, spacer arm length 11.4 Å , dissolved in DMSO), and glutaraldehyde (GA, water-soluble, membrane permeable). Chemical cross-linking was accomplished as described previously with some modifications (Ramjeesingh et al., 1999) . For more details, see the Supplemental Experimental Procedures.
Single-Molecule GFP Photobleaching
The single-molecule photobleaching experiments were performed as previously described (Ulbrich and Isacoff, 2007) with some modifications. TMCO1-GFP expressing in living HeLa cells was excited with a 488 nm laser through a TIRF objective (1003, oil, N.A. = 1.46; Leica DMI6000). For more details, see the Supplemental Experimental Procedures.
Preparation of Giant Liposomes and Electrical Recording
The purified wild-type TMCO1 and the mutants were reconstituted into lipid vesicles followed by dehydrate and hydrate processes. The giant liposome recording was performed by Axon200B patch-clamp system as previously described (Li et al., 2007) . Asymmetrical solutions of 10:1 salt gradients (pipette solution, 150 mM KCl; bath solution, 15 mM KCl) were used. Currents were low-pass filtered at 1 or 10 kHz and sampled at 10 kHz or 100 kHz. Liquid junction potentials were calculated using JPCalc software (P. Barry, University of South Wales, Sydney, Australia).
Mice TMCO1 knockout mice were generated by Shanghai Nanfang Laboratory for Model Organisms (Shanghai, China) using TALEN methods. TALENs targeting Exon1 of the TMCO1 gene was constructed by the Golden gate method. For more details and KO mouse-related assays, see the Supplemental Experimental Procedures. All animal experiments were reviewed and approved by the Institute of Zoology Institutional Animal Care and Use Committee and were conducted according to the committee's guidelines.
Statistical Analysis
Data are expressed as the mean ± SEM, and the statistical significance of differences between different groups was assessed using the t test or ANOVA with p < 0.05. 
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